Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • IIAR
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • IIAR
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

silibinin

  • You have access
    Hypoxia-inducible Factor-1α Suppression in Ovarian Clear-cell Carcinoma Cells by Silibinin Administration
    MARIKO MIYAZAWA, MASANORI YASUDA, MASAKI MIYAZAWA, NAOKI OGANE, TOMOMI KATOH, MITSUTAKE YANO, TAKESHI HIRASAWA, MIKIO MIKAMI and HITOSHI ISHIMOTO
    Anticancer Research December 2020, 40 (12) 6791-6798; DOI: https://doi.org/10.21873/anticanres.14702
  • You have access
    Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-Treatment
    JASMINE M. MANOUCHEHRI and MICHAEL KALAFATIS
    Anticancer Research December 2017, 37 (12) 6593-6599;
  • You have access
    The Effect of Silibinin in Enhancing Toxicity of Temozolomide and Etoposide in p53 and PTEN-mutated Resistant Glioma Cell Lines
    RASHID ELHAG, ELIZABETH A. MAZZIO and KARAM F.A. SOLIMAN
    Anticancer Research March 2015, 35 (3) 1263-1269;
  • You have access
    Silibinin Administration Improves Hepatic Failure Due to Extensive Liver Infiltration in a Breast Cancer Patient
    JOAQUIM BOSCH-BARRERA, BRUNA COROMINAS-FAJA, ELISABET CUYÀS, BEGOÑA MARTIN-CASTILLO, JOAN BRUNET and JAVIER A. MENENDEZ
    Anticancer Research August 2014, 34 (8) 4323-4327;
  • You have access
    Silibinin Down-regulates Expression of Secreted Phospholipase A2 Enzymes in Cancer Cells
    ALBERT HAGELGANS, BRIT NACKE, MARIA ZAMARAEVA, GABRIELE SIEGERT and MARIO MENSCHIKOWSKI
    Anticancer Research April 2014, 34 (4) 1723-1729;
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire